D-0724-2021 Class II Ongoing

Recalled by Noven Pharmaceuticals Inc — Miami, FL

FDA drug recall D-0724-2021 was initiated by Noven Pharmaceuticals Inc on Jul 30, 2021 and is designated Class II. Reason for recall: Failed Stability Specifications; out of specification for shear. The recall status is ongoing. Affected quantity: 223,382 boxes.

Recall details

Product Type
Drugs
Report Date
Aug 25, 2021
Initiation Date
Jul 30, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
223,382 boxes

Product description

Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx Only a) 2 Systems NDC 68968-0514-2 b) 8 Systems NDC 68968-0514-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186

Reason for recall

Failed Stability Specifications; out of specification for shear.

Distribution pattern

Nationwide.

Code information

Lots: 88542 Exp. 03/2022; 88227 Exp. 12/2021; 88696 Exp. 05/2022; 89357 Exp. 08/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0724-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0724-2021. Report a data issue: hello@regdatalab.com.